Medix ProClot
Hong Kong – Overseas Projects Platform / Signature Project
Hong Kong – Overseas Projects Platform / Signature Project
About this project
Medix ProClot is an agile medical innovator developing next-generation hemostatic (blood-clotting) solutions designed for both human and veterinary applications. By eliminating traditional prescription barriers and addressing regional supply chain inefficiencies, we deliver immediate, high-efficacy wound care across Asia-Pacific and emerging global markets.
**Core Innovation & Competitive Edge**
**Superior Efficacy:** Field-tested performance surpassing incumbent trauma gels (e.g., QuikClot, Celox), achieving rapid hemostasis for critical and everyday wound care.
**Unlocking the Prescription Gap:** Traditional hemostatic agents in APAC often require doctors' prescriptions, creating costly delays for basic bleeding management. We offer direct-access, highly effective solutions that lower barriers for end-users.
**Optimized Unit Economics & LTV:** Redesigned from cumbersome 30ml bulk units to compact 10ml and 20ml portable formats. This right-sizing accelerates consumption velocity and maximizes Customer Lifetime Value (LTV).
**Taiwan Manufacturing Excellence:** Partnered with leading Taiwanese CMOs holding extensive US FDA and TFDA clearance track records, ensuring top-tier regulatory compliance and manufacturing quality.
**Market Traction & Growth Momentum**
**Rapid APAC Rollout:** Secured MOUs across 4 APAC countries within our first year of operation.
**Proven Market Pull:** Sustaining strong organic demand without discounting. Recent trade showcases generated 160+ consumer waitlists, along with direct procurement inquiries from national defense units.
**Disrupting Legacy Distribution:** Traditional distributors of legacy brands face rigid bureaucracy, stock dumping, and a lack of local customer support. We offer direct, agile collaboration backed by genuine localized service—attracting top-tier regional distributors to our network.
**Impact-Driven Business Model**
**Direct-to-Distributor Structure:** Eliminates unnecessary middle layers to protect profit margins for all channel partners.
**ESG & Social Impact Marketing:** Brand awareness driven by direct support to stray animal shelters, capturing high consumer willingness-to-pay through social value.
**Subscription & Event Packages:** Expanding B2B channels through athletic event emergency kits (e.g., cycling event packages) and recurring membership models.